KRAS and colorectal cancer: Although the specific biological mechanisms underlying the differential effects of KRAS mutations are not yet fully understood, it has been demonstrated that the germline biallelic inactivation of the MUTYH (MutY Homolog) gene is associated with the occurrence of colorectal cancer bearing KRAS p.G12C and PIK3CA p.Q546K mutations [23].